These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2197092)

  • 1. Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter.
    López-Brea M; Alarcón T
    Eur J Clin Microbiol Infect Dis; 1990 May; 9(5):345-7. PubMed ID: 2197092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the emergence of resistance to lomefloxacin in vitro.
    Kanematsu M; Greenwood D
    Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):741-5. PubMed ID: 2506046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain.
    Alarcón T; Pita J; López-Brea M; Piddock LJ
    J Antimicrob Chemother; 1993 Oct; 32(4):605-9. PubMed ID: 8288502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to fluoroquinolones in Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Rydberg J; Larsson C; Miörner H
    Scand J Infect Dis; 1994; 26(3):317-20. PubMed ID: 7939432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolone resistance from a transferable plasmid.
    Martínez-Martínez L; Pascual A; Jacoby GA
    Lancet; 1998 Mar; 351(9105):797-9. PubMed ID: 9519952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
    Piddock LJ; Hall MC; Walters RN
    J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between ciprofloxacin resistance and extended-spectrum beta-lactamase production in Escherichia coli and Klebsiella pneumoniae strains.
    Tolun V; Küçükbasmaci O; Törümküney-Akbulut D; Catal C; Anğ-Küçüker M; Anğ O
    Clin Microbiol Infect; 2004 Jan; 10(1):72-5. PubMed ID: 14706090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
    Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin.
    Fendukly F; Karlsson I; Hanson HS; Kronvall G; Dornbusch K
    APMIS; 2003 Sep; 111(9):857-66. PubMed ID: 14510643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr.
    Wang M; Sahm DF; Jacoby GA; Zhang Y; Hooper DC
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1400-1. PubMed ID: 15047552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea.
    Shin JH; Jung HJ; Lee JY; Kim HR; Lee JN; Chang CL
    Microb Drug Resist; 2008 Sep; 14(3):221-6. PubMed ID: 18707554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
    Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
    So W; Crandon JL; Nicolau DP
    J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
    Becnel Boyd L; Maynard MJ; Morgan-Linnell SK; Horton LB; Sucgang R; Hamill RJ; Jimenez JR; Versalovic J; Steffen D; Zechiedrich L
    Antimicrob Agents Chemother; 2009 Jan; 53(1):229-34. PubMed ID: 18838594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance in potentially pathogenic and non-pathogenic Escherichia coli strains isolated from healthy ruminants.
    Orden JA; Ruiz-Santa-Quiteria JA; Cid D; Díez R; Martínez S; de la Fuente R
    J Antimicrob Chemother; 2001 Sep; 48(3):421-4. PubMed ID: 11533010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
    Martínez-Martínez L; Fernández F; Perea EJ
    J Antimicrob Chemother; 1999 Feb; 43(2):277-9. PubMed ID: 11252335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variants.
    Fung-Tomc J; Gradelski E; Huczko E; Minassian B; Bonner DP
    Int J Antimicrob Agents; 2001 Jul; 18(1):77-80. PubMed ID: 11463531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
    Aubert G; Puech C; Lucht F; Loboguerrero M; Denis M; Dorche G
    Pathol Biol (Paris); 1989 Oct; 37(8):881-7. PubMed ID: 2515519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.